|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2004-10-25
|
|
pubmed:abstractText |
To compare fluoxetine 20 to 60 mg/day with placebo for prevention of relapse of major depressive disorder in children and adolescents who had achieved Children's Depression Rating Scale, Revised scores of < or =28 during treatment with fluoxetine 20 to 60 mg.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0890-8567
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
43
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1397-405
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15502599-Administration, Oral,
pubmed-meshheading:15502599-Adolescent,
pubmed-meshheading:15502599-Child,
pubmed-meshheading:15502599-Depressive Disorder,
pubmed-meshheading:15502599-Double-Blind Method,
pubmed-meshheading:15502599-Female,
pubmed-meshheading:15502599-Fluoxetine,
pubmed-meshheading:15502599-Humans,
pubmed-meshheading:15502599-Male,
pubmed-meshheading:15502599-Placebos,
pubmed-meshheading:15502599-Recurrence,
pubmed-meshheading:15502599-Serotonin Uptake Inhibitors
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study.
|
|
pubmed:affiliation |
University of Texas Southwestern Medical Center at Dallas, Texas, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
